Inhibition of apoptosis in human laryngeal cancer cells by E6 and E7 oncoproteins of human papillomavirus 16

Journal of Cellular Biochemistry

Volumn 103, Issue 4, 2008, Pages 1125-1143

  Liu, Han Ching ^a   Chen, George G ^a   Vlantis, Alexander C ^a   Tse, Gary M ^a   Chan, Anthony T C ^a   Van Hasselt, C Andrew ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Bak; Bcl 2; HPV 16; Laryngeal cancer

Indexed keywords

LUCIFERASE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN E6; PROTEIN E7; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; GENE CONTROL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; LARYNX CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY;

APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN PAPILLOMAVIRUS 16; HUMANS; LARYNGEAL NEOPLASMS; ONCOGENE PROTEINS, VIRAL; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-BCL-2; REPRESSOR PROTEINS;

HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 40349108551     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21490     Document Type: Article

References (45)

1. Ayhan A, Yasui W, Yokozaki H, Seto M, Ueda R, Tahara E. 1994. Loss of heterozygosity at the bcl-2 gene locus and expression of bcl-2 in human gastric and colorectal carcinomas. Jpn J Cancer Res 85:584-591.
2. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM. 1987. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 61:962-971.
3. Bradford CR, Zhu S, Ogawa H, Ogawa T, Ubell M, Narayan A, Johnson G, Wolf GT, Fisher SG, Carey TE. 2003. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head Neck 25:654-661.
4. Brandwein MS, Nuovo GJ, Biller H. 1993. Analysis of prevalence of human papillomavirus in laryngeal carcinomas. Study of 40 cases using polymerase chain reaction and consensus primers. Ann Otol Rhinol Laryngol 102:309-313.
5. Carey TE. 1994. Head and neck tumor cell lines. In: Hay R, Gazdar A, Park J-G, editors. Atlas of human tumor cell lines. Orlando: Academic Press.
6. Cattaruzza MS, Maisonneuve P, Boyle P. 1996. Epidemiology of laryngeal cancer. Eur J Cancer B Oral Oncol 32B:293-305.
7. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC. 1995. Induction of apoptosis by the bcl-2 homologue bak. Nature 374:733-736.
8. Deng Y, Ren X, Yang L, Lin Y, Wu X. 2003. A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell 115:61-70.
9. Du J, Chen GG, Vlantis AC, Chan PK, Tsang RK, van Hasselt CA. 2004. Resistance to apoptosis of HPV 16-infected laryngeal cancer cells is associated with decreased bak and increased bcl-2 expression. Cancer Lett 205:81-88.
10. Franceschi S, Munoz N, Bosch XF, Snijders PJ, Walboomers JM. 1996. Human papillomavirus and cancers of the upper aerodigestive tract: A review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev 5:567-575.
11. Friedman M, Lim JW, Manders E, Schaffner AD, Kirshenbaum GL, Tanyeri HM, Caldarelli DD, Coon JS. 2001. Prognostic significance of bcl-2 and p53 expression in advanced laryngeal squamous cell carcinoma. Head Neck 23:280-285.
12. Georgiou A, Gomatos IP, Ferekidis E, Syrigos K, Bistola V, Giotakis J, Adamopoulos G, Androulakis G. 2001. Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma. Eur J Surg Oncol 27:574-580.
13. Gobe G, Rubin M, Williams G, Sawczuk I, Buttyan R. 2002. Apoptosis and expression of bcl-2, bcl-XL, and bax in renal cell carcinomas. Cancer Invest 20:324-332.
14. Gupta S. 2002. A decision between life and death during TNF-alpha-induced signaling. J Clin Immunol 22:185-194.
15. Haldar S, Basu A, Croce CM. 1997. Bcl2 is the guardian of microtubule integrity. Cancer Res 57:229-233.
16. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
17. Harada K, Ishibashi S, Miyashita T, Osuga J, Yagyu H, Ohashi K, Yazaki Y, Yamada N. 1997. Bcl-2 protein inhibits oxysterol-induced apoptosis through suppressing CPP32-mediated pathway. FEBS Lett 411:63-66.
18. Hauser U, Balz V, Carey TE, Grenman R, Van Lierop A, Scheckenbach K, Bier H. 2002. Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region. Head Neck 24:868-873.
19. Hirvikoski P, Kumpulainen E, Virtaniemi J, Johansson R, Haapasalo H, Marin S, Halonen P, Helin H, Raitiola H, Pukander J, KellokumpuLehtinen P, Kosma VM. 1997. p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma. J Clin Oncol 15: 3111-3120.
20. Huang SM, McCance DJ. 2002. Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF. J Virol 76:8710-8721.
21. Huang H, Zegarra-Moro OL, Benson D, Tindall DJ. 2004. Androgens repress bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells. Oncogene 23:2161-2176.
22. Iglesias M, Yen K, Gaiotti D, Hildesheim A, Stoler MH, Woodworth CD. 1998. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-lalpha. Oncogene 17:1195-1205.
23. Jackel MC, Sellmann L, Dorudian MA, Youssef S, Fuzesi L. 2000. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma. Laryngoscope 110:1339-1345.
24. Kroemer G. 1997. The proto-oncogene bcl-2 and its role in regulating apoptosis. Nat Med 3:614-620.
25. Magal SS, Jackman A, Ish-Shalom S, Botzer LE, Gonen P, Schlegel R, Sherman L. 2005. Downregulation of bax mRNA expression and protein stability by the E6 protein of human papillomavirus 16. J Gen Virol 86:611-621.
26. Martin B, Paesmans M, Berghmans T, Branle F, Ghisdal L, Mascaux C, Meert AP, Steels E, Vallot F, Verdebout JM, Lafitte JJ, Sculier JP. 2003. Role of bcl-2 as a prognostic factor for survival in lung cancer: A systematic review of the literature with meta-analysis. Br J Cancer 89: 55-64.
27. Moll UM, Wolff S, Speidel D, Deppert W. 2005. Transcription-independent pro-apoptotic functions of p53. Curr Opin Cell Biol 17:631-636.
28. Nees M, Geoghegan JM, Hyman T, Frank S, Miller L, Woodworth CD. 2001. Papillomavirus type 16 oncogenes downregulate expression of interferon- responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. J Virol 75: 4283-4296.
29. Oltvai ZN, Milliman CL, Korsmeyer SJ. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609-619.
30. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
31. Patel D, Huang SM, Baglia LA, McCance DJ. 1999. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J 18: 5061-5072.
32. Pater MM, Pater A. 1985. Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology 145:313-318.
33. Pignataro L, Pruneri G, Carboni N, Capaccio P, Cesana BM, Neri A, Buffa R. 1998. Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma. J Clin Oncol 16:3069-3077.
34. Puthenveettil JA, Frederickson SM, Reznikoff CA. 1996. Apoptosis in human papillomavirus 16 E7-, but not E6-immortalized human uroepithelial cells. Oncogene 13: 1123-1131.
35. Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B, Liebermann D. 1994. Immediate early up-regulation of bax expression by p53 but not TGF beta 1: A paradigm for distinct apoptotic pathways. Oncogene 9:1791-1798.
36. Stoppler H, Stoppler MC, Johnson E, Simbulan-Rosenthal CM, Smulson ME, Iyer S, Rosenthal DS, Schlegel R. 1998. The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis. Oncogene 17:1207-1214.
37. Thomadaki H, Scorilas A, Hindmarsh JT. 2006. BCL2 family of apoptosis-related genes: Functions and clinical implications in cancer. Crit Rev Clin Lab Sci 43:1-67.
38. Thomas M, Banks L. 1999. Human papillomavirus (HPV) E6 interactions with bak are conserved amongst E6 proteins from high and low risk HPV types. J Gen Virol 80:1513-1517.
39. Trask DK, Wolf GT, Bradford CR, Fisher SG, Devaney K, Johnson M, Singleton T, Wicha M. 2002. Expression of bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: Correlation with response to chemotherapy and organ preservation. Laryngoscope 112: 638-644.
40. Trinklein ND, Aldred SJ, Saldanha AJ, Myers RM. 2003. Identification and functional analysis of human transcriptional promoters. Genome Res 13:308-312.
41. Vlachtsis K, Nikolaou A, Markou K, Fountzilas G, Daniilidis I. 2005. Clinical and molecular prognostic factors in operable laryngeal cancer. Eur Arch Otorhinolaryngol 262:890-898.
42. Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, Howley PM. 1985. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 119:361-366.
43. Yuan H, Fu F, Zhuo J, Wang W, Nishitani J, An DS, Chen ISY, Liu X. 2005. Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis. Oncogene 24:5069-5078.
44. Zhan Q, Fan S, Bae I, Guillouf C, Liebermann DA, O'Connor PM, Fornace AJ, Jr. 1994. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 9:3743-3751.
45. zur Hausen H. 2000. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92:690-698.